Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. (2021)
Attributed to:
MRC Centre for Neurodevelopmental Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-22379-7
PubMed Identifier: 33846320
Publication URI: http://europepmc.org/abstract/MED/33846320
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723